Legend Biotech (LEGN) Other Non-Current Liabilities (2020 - 2023)
Legend Biotech (LEGN) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $56000.0 as the latest value for Q4 2023.
- For the quarter ending Q4 2023, Other Non-Current Liabilities fell 75.97% year-over-year to $56000.0, compared with a TTM value of $56000.0 through Dec 2023, down 75.97%, and an annual FY2023 reading of $56000.0, down 75.97% over the prior year.
- Other Non-Current Liabilities was $56000.0 for Q4 2023 at Legend Biotech, down from $233000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $554000.0 in Q4 2020 and bottomed at $56000.0 in Q4 2023.
- Average Other Non-Current Liabilities over 4 years is $309750.0, with a median of $314500.0 recorded in 2021.
- The sharpest move saw Other Non-Current Liabilities fell 28.52% in 2021, then plummeted 75.97% in 2023.
- Year by year, Other Non-Current Liabilities stood at $554000.0 in 2020, then fell by 28.52% to $396000.0 in 2021, then tumbled by 41.16% to $233000.0 in 2022, then tumbled by 75.97% to $56000.0 in 2023.
- Business Quant data shows Other Non-Current Liabilities for LEGN at $56000.0 in Q4 2023, $233000.0 in Q4 2022, and $396000.0 in Q4 2021.